Alkeon Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-853,845
| Closed | -$54.5M | – | 99 |
|
|
2025
Q1 | $54.5M | Hold |
853,845
| – | – | 0.11% | 51 |
|
|
2024
Q4 | $104M | Buy |
853,845
+220,000
| +35% | +$26.7M | 0.21% | 38 |
|
|
2024
Q3 | $79.2M | Buy |
633,845
+75,000
| +13% | +$9.37M | 0.14% | 48 |
|
|
2024
Q2 | $88.3M | Buy |
558,845
+100,000
| +22% | +$15.8M | 0.14% | 48 |
|
|
2024
Q1 | $59.4M | Buy |
458,845
+100,000
| +28% | +$12.9M | 0.1% | 54 |
|
|
2023
Q4 | $34.6M | Sell |
358,845
-100,000
| -22% | -$9.64M | 0.08% | 61 |
|
|
2023
Q3 | $55.6M | Sell |
458,845
-50,000
| -10% | -$6.06M | 0.1% | 58 |
|
|
2023
Q2 | $58.3M | Sell |
508,845
-203,989
| -29% | -$23.4M | 0.1% | 59 |
|
|
2023
Q1 | $98.2M | Buy |
712,834
+39,222
| +6% | +$5.41M | 0.22% | 46 |
|
|
2022
Q4 | $87.3M | Sell |
673,612
-557,784
| -45% | -$72.3M | 0.34% | 47 |
|
|
2022
Q3 | $136M | Buy |
1,231,396
+75,000
| +6% | +$8.29M | 0.44% | 39 |
|
|
2022
Q2 | $86.7M | Sell |
1,156,396
-19,400
| -2% | -$1.45M | 0.23% | 53 |
|
|
2022
Q1 | $91.9M | Buy |
1,175,796
+80,796
| +7% | +$6.31M | 0.18% | 72 |
|
|
2021
Q4 | $98.6M | Buy |
1,095,000
+1,006,000
| +1,130% | +$90.6M | 0.18% | 79 |
|
|
2021
Q3 | $8.23M | Buy |
+89,000
| New | +$8.23M | 0.01% | 140 |
|
|
2020
Q1 | – | Sell |
-20,000
| Closed | -$2.58M | – | 136 |
|
|
2019
Q4 | $2.58M | Buy |
+20,000
| New | +$2.58M | 0.01% | 94 |
|